Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Pamiparib
Trade Name
Synonyms BGB-290|BGB290
Drug Descriptions

Pamiparib (BGB-290) inhibits PARP1 and PARP2, potentially resulting in increased sensitivity to DNA damaging agents (AACR; 2015. Abstract nr 1651, PMID: 32652442).

DrugClasses PARP Inhibitor (Pan) 30
CAS Registry Number 1446261-44-4
NCIT ID C120553


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Bevacizumab + Pamiparib Bevacizumab Pamiparib 0 0
Cabozantinib + Pamiparib Cabozantinib Pamiparib 0 1
Fluorouracil + Hydroxyurea + Pamiparib + Tislelizumab Fluorouracil Hydroxyurea Pamiparib Tislelizumab 0 1
Olaparib + Pamiparib + Temozolomide Olaparib Pamiparib Temozolomide 0 1
Pamiparib Pamiparib 2 5
Pamiparib + Radiotherapy Pamiparib Radiotherapy 1 0
Pamiparib + Temozolomide Pamiparib Temozolomide 0 6
Pamiparib + Tislelizumab Pamiparib Tislelizumab 0 3

Additional content available in CKB BOOST